Tilray sells beer, cannabis, medicines and hemp foods, and its sales keep growing. In fiscal 2026, overhead still swallowed almost all the profit on its goods, and new shares helped fund the business.
A pint of craft beer in a pub may be the closest most people come to Tilray Brands. It owns US beers such as SweetWater and Blue Point, and in March 2026 it bought BrewDog, including its breweries and pubs in the UK, Australia and the United States. Tilray also grows cannabis in Canada, Portugal and Germany, sells it in Canada and to patients in many countries, distributes medicines in Germany and sells hemp foods. Whatever the product, it makes or buys it, brands it and sells it.
Beer drinkers reach it through distributors and, since the BrewDog deal, through Tilray's own pubs. With BrewDog included, beer and spirits became its largest line of sales in the quarter to August 2026. In cannabis, Tilray reports the highest revenue in Canada, and patients, pharmacies and hospitals return for a steady supply made to medicine-grade standards. Tilray says it runs some of the highest-quality, lowest-cost cannabis growing in Canada, and it now sends Canadian flower to Europe. What it keeps depends on making the goods cheaply and on the overhead of running many brands across several countries.
Create a free account to unlock the rest of this report and access all published research.
This report is general, non-personalized research provided solely for informational and educational purposes. It is not financial or investment advice, a personalized recommendation, an offer to the public, a solicitation, an instruction to buy, sell or hold a financial instrument, or an invitation to engage in an investment activity. ReasyPort is not an authorised or regulated investment firm and does not provide a MiFID II investment service.
This report is based on primary and public sources identified in the report, including issuer filings, annual and interim reports, regulated announcements, investor-relations materials, market data and, where relevant, institutional macroeconomic publications. Facts should be read separately from interpretations, estimates and opinions.
Text, analyses, summaries, translations and charts may be produced with the support of Artificial Intelligence and are subjected to deterministic data and consistency checks before publication. These controls reduce, but cannot eliminate, errors, omissions or incorrect interpretations. Editorial responsibility for publication remains with the producer identified above.
This report is based on a structured review of public information, including the issuer's official filings, annual and interim reports, investor-relations materials, regulated announcements, exchange or supervisory disclosures where available, and other institutional or publicly available sources.
Financial figures may be presented in the issuer's reporting currency and may follow the accounting classifications used in the original disclosures. Market data, daily price history, foreign-exchange translation, and valuation chart coverage may be delayed, incomplete, unavailable, or omitted where a reliable local-market series is not available.
ReasyPort View labels, fair values, forecasts, scenarios, price references and other forward-looking statements are editorial estimates or opinions, not facts or trading instructions. They depend on the assumptions, methodology, market price and information available on the stated reference date and may change without notice. The report is not monitored or updated in real time.
Any relationship, compensation, material holding or other circumstance known to ReasyPort that could reasonably impair the objectivity of a report must be disclosed with that report. Questions, corrections and potential conflicts may be reported through the legal contact shown above.
Public and primary sources, automated extraction and data providers may contain material errors, omissions, inaccuracies, restatements or delays. Accuracy, completeness and timeliness are therefore not guaranteed, and important information should be checked against the original source before it is used.
To the maximum extent permitted by applicable law, ReasyPort, the author, the publisher and the persons involved in producing the report are not liable for losses arising from decisions made solely in reliance on this report. Nothing in this notice excludes or limits any liability that cannot lawfully be excluded or limited.
Any investment decision should be made independently, if appropriate with the support of a licensed financial adviser. Investments in financial instruments involve risks, including the possible partial or total loss of invested capital.
Research methodology, assumptions and disclosuresMeaning of ReasyPort View